| First Author | Leon J | Year | 2017 |
| Journal | Cell Rep | Volume | 20 |
| Issue | 6 | Pages | 1360-1371 |
| PubMed ID | 28793260 | Mgi Jnum | J:254867 |
| Mgi Id | MGI:6104098 | Doi | 10.1016/j.celrep.2017.07.024 |
| Citation | Leon J, et al. (2017) Peripheral Elevation of a Klotho Fragment Enhances Brain Function and Resilience in Young, Aging, and alpha-Synuclein Transgenic Mice. Cell Rep 20(6):1360-1371 |
| abstractText | Cognitive dysfunction and decreased mobility from aging and neurodegenerative conditions, such as Parkinson and Alzheimer diseases, are major biomedical challenges in need of more effective therapies. Increasing brain resilience may represent a new treatment strategy. Klotho, a longevity factor, enhances cognition when genetically and broadly overexpressed in its full, wild-type form over the mouse lifespan. Whether acute klotho treatment can rapidly enhance cognitive and motor functions or induce resilience is a gap in our knowledge of its therapeutic potential. Here, we show that an alpha-klotho protein fragment (alphaKL-F), administered peripherally, surprisingly induced cognitive enhancement and neural resilience despite impermeability to the blood-brain barrier in young, aging, and transgenic alpha-synuclein mice. alphaKL-F treatment induced cleavage of the NMDAR subunit GluN2B and also enhanced NMDAR-dependent synaptic plasticity. GluN2B blockade abolished alphaKL-F-mediated effects. Peripheral alphaKL-F treatment is sufficient to induce neural enhancement and resilience in mice and may prove therapeutic in humans. |
